Curtiss Puckett

572 total citations
11 papers, 236 citations indexed

About

Curtiss Puckett is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Curtiss Puckett has authored 11 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Curtiss Puckett's work include Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (5 papers). Curtiss Puckett is often cited by papers focused on Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Management and Research (5 papers). Curtiss Puckett collaborates with scholars based in United States and Qatar. Curtiss Puckett's co-authors include Curtis Triplitt, John M. Adams, Eugênio Cersósimo, Ralph A. DeFronzo, David Maggs, Muhammad Abdul‐Ghani, Ahmed Khattab, Ralph A. DeFronzo, Geoffrey D. Clarke and Naim Alkhouri and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Curtiss Puckett

10 papers receiving 219 citations

Peers

Curtiss Puckett
Leobardo Sauque‐Reyna United States
Carlos Trescolí Spain
Matt Brauer United States
Heike Schlichthaar United Kingdom
Ken Yajima Japan
Xiaolin Dong China
Shirley Hulme United Kingdom
Valérie Pilorget France
Sid McNulty United Kingdom
Thomas Segiet Germany
Leobardo Sauque‐Reyna United States
Curtiss Puckett
Citations per year, relative to Curtiss Puckett Curtiss Puckett (= 1×) peers Leobardo Sauque‐Reyna

Countries citing papers authored by Curtiss Puckett

Since Specialization
Citations

This map shows the geographic impact of Curtiss Puckett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtiss Puckett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtiss Puckett more than expected).

Fields of papers citing papers by Curtiss Puckett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtiss Puckett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtiss Puckett. The network helps show where Curtiss Puckett may publish in the future.

Co-authorship network of co-authors of Curtiss Puckett

This figure shows the co-authorship network connecting the top 25 collaborators of Curtiss Puckett. A scholar is included among the top collaborators of Curtiss Puckett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtiss Puckett. Curtiss Puckett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Abdul‐Ghani, Muhammad, Curtiss Puckett, Aurora Merovci, et al.. (2025). Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study. BMJ Open Diabetes Research & Care. 13(2). e004981–e004981. 1 indexed citations
2.
Abdul‐Ghani, Muhammad, Curtiss Puckett, John M. Adams, et al.. (2022). Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes ( EDICT ). Diabetes Obesity and Metabolism. 24(5). 899–907. 26 indexed citations
3.
Abdul‐Ghani, Tamam, Curtiss Puckett, John M. Adams, et al.. (2022). T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study. Metabolism. 128. 155094–155094. 1 indexed citations
4.
Abdul‐Ghani, Tamam, Curtiss Puckett, John M. Adams, et al.. (2022). Type 2 diabetes subgroups and response to glucose‐lowering therapy: Results from the EDICT and Qatar studies. Diabetes Obesity and Metabolism. 24(9). 1810–1818. 8 indexed citations
5.
Puckett, Curtiss, et al.. (2021). Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes. The Journal of Clinical Endocrinology & Metabolism. 106(12). 3497–3504. 4 indexed citations
6.
7.
Abdul‐Ghani, Muhammad, Eugênio Cersósimo, Naim Alkhouri, et al.. (2020). 184-OR: Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM. Diabetes. 69(Supplement_1).
8.
Abdul‐Ghani, Muhammad, Curtiss Puckett, John M. Adams, et al.. (2020). Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT. Diabetes Care. 44(2). 433–439. 36 indexed citations
9.
Abdul‐Ghani, Muhammad, Curtiss Puckett, Curtis Triplitt, et al.. (2018). Durable HbA1c Reduction with Initial Combination Therapy with Metformin/Pioglitazone/Exenatide in Subjects with New-Onset Diabetes—Six-Year Follow-Up of the EDICT Study. Diabetes. 67(Supplement_1). 5 indexed citations
10.
11.
Abdul‐Ghani, Muhammad, Curtiss Puckett, John M. Adams, et al.. (2013). 1.8 Initial Triple Combination Therapy is Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed T2DM (72-OR). 11(3). 80–81. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leobardo Sauque‐Reyna Breakdown of academic impact, for papers by Carlos Trescolí Breakdown of academic impact, for papers by Matt Brauer Breakdown of academic impact, for papers by Heike Schlichthaar Breakdown of academic impact, for papers by Ken Yajima Breakdown of academic impact, for papers by Xiaolin Dong Breakdown of academic impact, for papers by Shirley Hulme Breakdown of academic impact, for papers by Valérie Pilorget Breakdown of academic impact, for papers by Sid McNulty Breakdown of academic impact, for papers by Thomas Segiet
Rankless by CCL
2026